Aldeyra Therapeutics Inc
NASDAQ:ALDX

Watchlist Manager
Aldeyra Therapeutics Inc Logo
Aldeyra Therapeutics Inc
NASDAQ:ALDX
Watchlist
Price: 5.01 USD -4.57% Market Closed
Market Cap: 301.4m USD

Operating Margin
Aldeyra Therapeutics Inc

0%
Current
0%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-45.2m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Aldeyra Therapeutics Inc
Glance View

Market Cap
301.4m USD
Industry
Biotechnology

Aldeyra Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in Lexington, Massachusetts and currently employs 12 full-time employees. The company went IPO on 2014-05-02. The firm's lead product candidate, reproxalap, is a treatment in late-stage development for dry eye disease (DED) and allergic conjunctivitis (AC). The company has additional product candidates in development for proliferative vitreoretinopathy (PVR), primary vitreoretinal lymphoma (PVRL) and other retinal diseases, autoimmune disease, and cancer. The firm's product development pipeline is focused on immune-mediated ocular diseases and select systemic diseases and encompasses two biological mechanisms of action: reactive aldehyde species (RASP) modulation and dihydrofolate reductase inhibition. The immunological activity of its product candidates generally leads to diminished levels of pathological inflammation through down-regulation of immune cell activation or proliferation.

ALDX Intrinsic Value
17.67 USD
Undervaluation 72%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-45.2m
/
Revenue
0
What is the Operating Margin of Aldeyra Therapeutics Inc?

Based on Aldeyra Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top